Disclosures for "α-Synuclein membrane-binding in the central and enteric nervous system in Parkinson’s disease ")
-
Dr. Gao has nothing to disclose.
-
Mr. Briano has nothing to disclose.
-
Ms. Komer has nothing to disclose.
-
Dr. Crawford has received personal compensation for serving as an employee of seres. Dr. Crawford has received personal compensation for serving as an employee of merck. Dr. Crawford has received personal compensation for serving as an employee of ferring. Dr. Crawford has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for seres. Dr. Crawford has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for ferring. Dr. Crawford has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for seres. Dr. Crawford has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for merck. Dr. Crawford has received stock or an ownership interest from seres. Dr. Crawford has received intellectual property interests from a discovery or technology relating to health care.
-
Dr. Henchcliffe has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. Dr. Henchcliffe has received personal compensation in the range of $0-$499 for serving as a Consultant for MedExcelCap. The institution of Dr. Henchcliffe has received research support from Weston Brain Institute. The institution of Dr. Henchcliffe has received research support from Blue Rock Therapeutics.
-
Dr. Lee has nothing to disclose.
-
Prof. Burré has received research support from NIH. Prof. Burré has received research support from Michael J. Fox Foundation. Prof. Burré has received personal compensation in the range of $500-$4,999 for serving as a Reviewer with NIH.